Tag: generic drug approval

30-Month Stay Explained: How Patent Litigation Delays Generic Drug Approval
30-Month Stay Explained: How Patent Litigation Delays Generic Drug Approval

Explore how the 30-month stay under the Hatch-Waxman Act delays generic drug approval through patent litigation, impacting costs and market access.

Read More
FDA Authorization of Generics: Legal Basis and Approval Process
FDA Authorization of Generics: Legal Basis and Approval Process

The FDA approves generic drugs through a strict legal process based on the Hatch-Waxman Act. Generics must match brand drugs in active ingredients, strength, and bioequivalence - not just cost. Over 90% of U.S. prescriptions are for generics, saving billions annually.

Read More

Latest Posts

Contact Us

SEND MESSAGE